Evidence map›Paper›PMID 35500021›Full record

ArticlePloS one2022

Downstream retraction of preprinted research in the life and medical sciences.

Michele Avissar-Whiting

Abstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Michele Avissar-WhitingResearch Square Company, Durham, North Carolina, United States of America.ORCID 0000-0003-0030-3135

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Retractions have been on the rise in the life and clinical sciences in the last decade, likely due to both broader accessibility of published scientific research and increased vigilance on the part of publishers. In this same period, there has been a greater than ten-fold increase in the posting of preprints by researchers in these fields. While this development has significantly accelerated the rate of research dissemination and has benefited early-career researchers eager to show productivity, it has also introduced challenges with respect to provenance tracking, version linking, and, ultimately, back-propagation of events such as corrigenda, expressions of concern, and retractions that occur on the journal-published version. The aim of this study was to understand the extent of this problem among preprint servers that routinely link their preprints to the corollary versions published in journals. To present a snapshot of the current state of downstream retractions of articles preprinted in three large preprint servers (Research Square, bioRxiv, and medRxiv), the DOIs of the journal-published versions linked to preprints were matched to entries in the Retraction Watch database. A total of 30 retractions were identified, representing only 0.01% of all content posted on these servers. Of these, 11 retractions were clearly noted by the preprint servers; however, the existence of a preprint was only acknowledged by the retracting journal in one case. The time from publication to retraction averaged 278 days, notably lower than the average for articles overall (839 days). In 70% of cases, retractions downstream of preprints were due-at least in part-to ethical or procedural misconduct. In 63% of cases, the nature of the retraction suggested that the conclusions were no longer reliable. Over time, the lack of propagation of critical information across the publication life cycle will pose a threat to the scholarly record and to scientific integrity. It is incumbent on preprint servers, publishers, and the systems that connect them to address these issues before their scale becomes untenable.

Indexed as

PublishingResearch PersonnelRetraction of Publication as TopicHumans

Identifiers

PMID35500021
PMCPMC9060331

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.